Vetoquinol S.A (VETO) | Stock Overview & Key Data

What is VETO's 52-week high and low?

In the last 52 weeks, Vetoquinol S.A reached a high of €91.50 (on February 13, 2026) and a low of €67.20 (on June 3, 2026).

What is the market cap and P/E ratio for VETO?

Curious about Vetoquinol S.A's size and valuation? Its market capitalization stands at 911.10M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.

Does VETO pay dividends? If so, what's the yield?

Yes, Vetoquinol S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.27%, and the company has paid an average of €0.85 per share annually over the past 3 years.

Who are Vetoquinol S.A's main competitors or similar companies to consider before investing?

When looking at Vetoquinol S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Ipsen S.A IPN	13.43B	Healthcare	Drug Manufacturers - Specialty & Generic	52.76%	40.77%
Boiron S.A BOI	446.21M	Healthcare	Drug Manufacturers - Specialty & Generic	20.43%	-26.99%
Euroapi S.A.S.U EAPI	121.46M	Healthcare	Drug Manufacturers - Specialty & Generic	1.60%	1.60%
AB Science S.A AB	76.77M	Healthcare	Drug Manufacturers - Specialty & Generic	-23.93%	-80.82%
CoreTech Limited MLCOT	1.26M	Healthcare	Drug Manufacturers - Specialty & Generic	-20.00%	100.00%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Vetoquinol S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Vetoquinol S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for VETO?

Looking at Vetoquinol S.A's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of VETO stock is held by insiders and institutions?

Wondering who owns Vetoquinol S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.

For more common questions about our data, please visit our About Data page.